NYMOX PHARMACEUTICAL CORP (NYMX)       0.3  -0.02 (-6.25%)

0.3  -0.02 (-6.25%)

BSP733981026 - Common Stock

TTM
(2022-9-30)
2021
(2021-12-31)
2020
(2020-12-31)
2019
(2019-12-31)
2018
(2018-12-31)
Revenue
0.000.0010.00K120.00K300.00K
Cost Of Goods
N/A0.000.0060.00K140.00K
Gross Profit
N/A0.000.0060.00K160.00K
Operating Expenses
11.13M12.50M11.73M13.38M10.80M
Operating Income
N/AN/AN/A-13.32M-10.64M
Interest Expense
-37.00K-33.00K-20.00K160.00K50.00K
Income Before Taxes
-8.05M-12.54M-11.74M-13.16M-10.59M
Income Tax
N/A0.000.000.000.00
Net Income
-8.05M-12.54M-11.74M-13.16M-10.59M
EBITDA
N/AN/AN/A-13.31MN/A
 
Per Share Data
EPS Diluted Total Ops
-0.09-0.15-0.16-0.19-0.18
 
Statistics
Gross Profit Margin
N/AN/AN/A50.00%53.33%
Profit Margin
N/AN/A-117400.00%-10966.67%-3530.00%
Operating Profit Margin
N/AN/AN/A-11100.00%-3546.67%

All data in USD

Charts